About Index Trending news
Lists
Pricing
Sutro Biopharma

Sutro Biopharma

Sutro Biopharma

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series D)
$26,000,000
Venture capital (Series C)
$36,500,000
Employees

Team size

50+
Xconomy

Celgene Narrows Its Relationship With Sutro, No Acquisition Coming

Health
$26,000,000 Venture capital (Series D)
FinSMEs

Sutro Biopharma Secures $26M in Series D Financing